Trouble reading this email? View it in your browser
European Federation of Pharmaceutical industries and associations

EFPIA Newsletter 14 February 2019


Diabetes partnership powering a healthier future

Winner of 2018 Prevention & Awareness Category

KiDS and Diabetes in Schools won the Prevention & Awareness Category at the 2018 Health Collaboration Awards.

Around one in five people in Europe is an unhealthy weight, putting them at increased risk of diabetes. Poland is a case in point. More than 20% of primary and secondary school children in Poland are overweight. 

The KiDS and Diabetes in Schools, an educational programme, was co-created by the International Diabetes Federation (IDF), the International Society for Pediatric and Adolescent Diabetes (ISPAD) and Sanofi. The goal was to make schools a safe and supportive environment for children with diabetes, to fight discrimination, and to prevent type 2 diabetes through education on lifestyle choices. Read more




Europe’s gamble with the future of medical innovation
14 February 2019

EFPIA notes the gamble on Europe’s future in medical innovation taken by the EU institutions in today’s trilogue meeting... Read more

Medicines verification system goes live across EU to better protect patients from falsified...
08 February 2019

The new system is a world-first for its stakeholder model, its scale, its use of new technologies and represents an... Read more




Stimulating the development of new medicines for children
14 February 2019 - Nathalie Moll

WeWontRest in our commitment to working with our partners in paediatric research to continue to discover, develop and... Read more

Highlights from DIA Europe 2019 – EFPIA team in the Middle of the Regulatory Buzz
08 February 2019

A blog by: Magda Chlebus, Sini Eskola, Nathalie Moll, Jana Nackberg, Giovanna Rizzetto and Pär Tellner Read more

There is plenty of buzz around genomics yet access to testing and treatments is still a challenge...
14 February 2019 - Tobias Helmstorf

How can Europe ensure that also European cancer patients benefit from those new treatments? Read more

European Medicines Verification System – is it worth it?
08 February 2019 - Mihai Rotaru

When it comes to patient safety, what level of risk are you willing to accept? What number is an acceptable number? Read more




Children keep us up at night
And #WeWontRest until we’ve helped make the world a healthier place for every single one of them. Read more

For The Chance To...
Millions of people wouldn't be here today if it wasn't for life-changing science. And many more wouldn't be living the... Read more




2019 China/EU Pharmaceutical Industry Forum
08 May 2019 (Hangzhou, China)

The workshop covers 4 different themes: Pharmaceuticals in the Environment, Pricing & Reimbursement, Compliance (marketing... Read more

ICHOM conference 2019: Redefining value through patient centered outcomes
02 May 2019 (Rotterdam, The Netherlands)

The world-leading event for providers, life sciences and industry on value-based healthcare Read more


What we are reading


EU institutions reach deal on SPC waiver
On 14 February 2019 (Politico Pro)

The European Commission, the European Parliament and EU countries today reached a provisional agreement on the... Read more

EU pharma stakeholders take action to tackle fake medicines
On 11 February 2019 (Euractiv)

A number of pharma stakeholders announced on 9 February the official launch of the European Medicines Verification System... Read more

UK government acknowledges delayed access to new drugs in no-deal Brexit
On 11 February 2019 (Politico Pro)

Patients in the U.K. could see slower access to innovative medicines and higher drug prices in the event of a no-deal... Read more